Related Experiment Video
Updated: Aug 25, 2026

Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide
Published on: May 12, 2023
SREBPs suppress IRS-2-mediated insulin signalling in the liver
Tomohiro Ide1, Hitoshi Shimano, Naoya Yahagi
1Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Abstract:
Insulin receptor substrate 2 (IRS-2) is the main mediator of insulin signalling in the liver, controlling insulin sensitivity. Sterol regulatory element binding proteins (SREBPs) have been established as transcriptional regulators of lipid synthesis. Here, we show that SREBPs directly repress transcription of IRS-2 and inhibit hepatic insulin signalling. The IRS-2 promoter is activated by forkhead proteins through an insulin response element (IRE). Nuclear SREBPs effectively replace and interfere in the binding of these transactivators, resulting in inhibition of the downstream PI(3)K/Akt pathway, followed by decreased glycogen synthesis. These data suggest a molecular mechanism for the physiological switching from glycogen synthesis to lipogenesis and hepatic insulin resistance that is associated with hepatosteatosis.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Regulation of the Unfolded Protein Response
PI3K/mTOR/AKT Signaling Pathway
Cell Specific Gene Expression
Experimental RNAi
The JAK-STAT Signaling Pathway